Thrombocytopaenia Clinical Trial
Official title:
Systematic Review of the Clinical and Cost Effectiveness of Treatments for Idiopathic (Immune) Thrombocytopenic Purpura (ITP): Direct Meta Analysis
The purpose of the meta-analysis was to explore the efficacy of eltrombopag versus placebo (standard of care)
Meta-analysis of three studies: Bussell 2007 & Bussell 2009 & RAISE (TRA102537). ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT01440374 -
A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia
|
Phase 2 | |
Completed |
NCT01957176 -
A Rollover Study to Provide Continued Treatment With Eltrombopag
|
Phase 4 | |
Withdrawn |
NCT01055600 -
Milk-only Lactation Study for Patients on Eltrombopag
|
Phase 4 | |
Completed |
NCT01147809 -
Safety and Efficacy Study for Solid Tumor Patients Treated With Eltrombopag
|
Phase 2 | |
Terminated |
NCT02158936 -
A Study of Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS)
|
Phase 3 | |
Completed |
NCT00358540 -
Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And Ifosfamide
|
Phase 1 | |
Completed |
NCT00102726 -
SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy
|
Phase 2 | |
Completed |
NCT01236014 -
Indirect Comparison Between Eltrombopag & Romiplostim
|
N/A | |
Completed |
NCT01657552 -
Eltrombopag/Boceprevir and Eltrombopag/Telaprevir Drug-Drug Interaction Study In Healthy Adult Subjects
|
Phase 1 |